News

Yemaachi News

July 1, 2021

“The Scientist” Feature: Quest for Research Freedom Fuels African Biotech Boom

Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab
July 1, 2021

July 2021 Newsletter

The third issue of the Yemaachi Bulletin covers a key milestone marked by Yemaachi as well as other activities from the past 3 months
May 30, 2021

H3D Partners with Yemaachi to Utilise African Genetic Diversity to Develop New Tools for Improving Treatment Outcomes for the African Patient Populations

The Holistic Drug Discovery and Development (H3D) Centre at the University of Cape Town (UCT) has entered into a strategic partnership with Yemaachi Biotech, to exploit African genetic diversity by identifying new therapies and platforms that optimize cancer treatments for African patient populations.
March 31, 2021

March 2021 Newsletter

The second issue of the Yemaachi Bulletin covers an exciting new platform and a promising collaboration, as well as other activities from the past 3 months
February 19, 2021

Public Engagement on COVID-19 Vaccine Roll Out Plan

Yaw Bediako, PhD joined a distinguished panel of Ghana’s healthcare leaders and government representatives to engage the public on the nation’s COVID-19 vaccine roll out plan. […]
December 16, 2020

Yemaachi’s First Publication

Dr. Ella Amoako, Desmond Jumbam and Dr. Yaw Bediako authored an editorial in the January 2021 edition of BMJ Global Health, discussing the impact that excluding African participants from clinical trials has on childhood cancer research.
December 14, 2020

December 2020 Newsletter

The maiden edition of the Yemaachi Bulletin reveals the progress we made so far with fitting out a new space for our lab, and an introduces of a new Google-sponsored project.